肿瘤学 SCIE

期刊简介预计审稿时间： 较慢,6-12周

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

尽管实验室和临床癌症研究需要紧密联系，但基础层面的观察结果往往与医学应用相距甚远。本期刊致力于加速实验结果向临床的转化，并再次返回实验室进行进一步研究。这项工作的根本目的是推进与临床相关的癌症知识，并改善恶性疾病的预防、诊断和治疗效果。该期刊发表来自世界各地癌症项目的重要临床研究，以及重要的转化实验室发现、小型评论（邀请和提交）以及对肿瘤学领域不断发展和有争议的话题的深入讨论。该期刊的一个独特之处是新开设了一个栏目，重点关注快速同行评审和随后发表 1 期和 2 期临床癌症试验的简短报告，目标是确保高质量的临床癌症研究迅速进入公共领域，无论试验最终得出的疗效或毒性结论如何。

《Oncology》(肿瘤学)编辑部通讯方式为KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。